A way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
In research published in the medical journal Brain, Saint Louis University researcher Daniela Salvemini, Ph.D. and colleagues within SLU, the National Institutes of Health (NIH) and other academic institutions have discovered a way to block a pain pathway in animal models of chronic neuropathic pain including pain caused by chemotherapeutic agents and bone cancer pain suggesting a promising new approach to pain relief.
The scientific efforts led by Salvemini, who is professor of pharmacological and physiological sciences at SLU, demonstrated that turning on a receptor in the brain and spinal cord counteracts chronic nerve pain in male and female rodents. Activating the A3 receptor – either by its native chemical stimulator, the small molecule adenosine, or by powerful synthetic small molecule drugs invented at the NIH – prevents or reverses pain that develops slowly from nerve damage without causing analgesic tolerance or intrinsic reward (unlike opioids).
An Unmet Medical Need
Pain is an enormous problem. As an unmet medical need, pain causes suffering and comes with a multi-billion dollar societal cost. Current treatments are problematic because they cause intolerable side effects, diminish quality of life and do not sufficiently quell pain.
The most successful pharmacological approaches for the treatment of chronic pain rely on certain “pathways”: circuits involving opioid, adrenergic, and calcium channels.
For the past decade, scientists have tried to take advantage of these known pathways – the series of interactions between molecular-level components that lead to pain. While adenosine had shown potential for pain-killing in humans, researchers had not yet successfully leveraged this particular pain pathway because the targeted receptors engaged many side effects.
A Key to Pain Relief
In this research, Salvemini and colleagues have demonstrated that activation of the A3 adenosine receptor subtype is key in mediating the pain relieving effects of adenosine.
“It has long been appreciated that harnessing the potent pain-killing effects of adenosine could provide a breakthrough step towards an effective treatment for chronic pain,” Salvemini said. “Our findings suggest that this goal may be achieved by focusing future work on the A3AR pathway, in particular, as its activation provides robust pain reduction across several types of pain.”
The Latest on: Pain relief
via Google News
The Latest on: Pain relief
- 6 common causes of lower back pain and 5 ways to treat iton March 4, 2021 at 1:18 pm
An estimated 29 percent of Americans (that's roughly 96 million people) suffer from back pain each year, yet the cause of back pain remains a mystery for many people. That's likely due in part to the ...
- Senate takes first step toward passing $1.9 trillion Covid relief bill — here's what happens nexton March 4, 2021 at 12:20 pm
Senate Democrats hope to pass the $1.9 trillion coronavirus relief bill by this weekend as they try to renew unemployment aid programs.
- Digital app can help chronic pain sufferers manage their painon March 4, 2021 at 9:29 am
For the first time, an app has been shown to reduce key symptoms of chronic pain. A UHN-led study evaluated the impact of Manage My Pain (MMP), a digital health solution developed by ManagingLife, on ...
- "Embarrassed" Cuomo apologizes for "pain I've caused," but says he won't resign as New York's governoron March 4, 2021 at 3:57 am
New York Governor Andrew Cuomo said Wednesday that he won't resign from office amid growing calls for him to step down over sexual harassment allegations. After a third woman came forward to allege ...
- Can AI fight racial bias in treating knee pain?on March 4, 2021 at 2:19 am
Traditional approaches to pain management don't treat all patients the same. Artificial intelligence may eliminate racial bias and level the playing field.
- Working from home during Covid is causing more back and neck pain — here's how to find reliefon March 3, 2021 at 6:21 am
Here are the common factors contributing to back pain during the pandemic, plus tips and exercises to feel better today.
- Hisamitsu America, Marketers of the Salonpas Line of Pain-Relieving Products, Announce Launch of Salonpas(R) Arthritis Pain Relief Gelon March 1, 2021 at 9:10 am
FLORHAM PARK, NJ / ACCESSWIRE / March 1, 2021 / Hisamitsu America, a division of Hisamitsu Pharmaceutical Co., and the manufacturers of the Salonpas® line of pain-relieving products, announce the ...
- Kailo Patch Reviews – Best Pain Relief Patch? – Product Review by Mike Vaughnon February 25, 2021 at 3:36 pm
The Kailo Pain Relief Patch is a special patch that you can apply to painful areas of your body and it doesn't work in a chemical way. Check out our review for more details! Kailo Patch The Kailo Pain ...
- AppliedVR Completes Pivotal Trial Finding Virtual Reality Is a Holistic Treatment for Chronic Painon February 24, 2021 at 8:17 pm
AppliedVR, a pioneer advancing the next generation of digital medicine, today announced results from its pivotal randomized controlled trial (RCT), ev ...
- New pain treatment reduces need for narcoticson February 24, 2021 at 11:24 am
One in seven teens have reportedly misused opioids in high school, according to the CDC. Now, doctors are trying to find a way to prevent that from happening, and it starts with a way to treat pain ...
via Bing News